搜索结果11-20 的 20176 / monoclonal antibody

  1. 血液科- 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  2. 血液科- 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

  3. 血液科- 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

  4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

  5. 血液科- 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

  6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

  7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell ...

  8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  9. 血液科- 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

  10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...